NT5E and B-cell chronic lymphocytic leukemia: As previously described [23], although the expression level of CD73 per B-cells in most CLL patients is less than the controls (Figure 3B), the actual number of CD73+CD19+ cells in PBMCs are increased due to the high numbers of B-cells in CLL patients (Figure 3A).